Key result
Myxedema heart disease is a rare entity that should be suspected in patients with unexplained heart failure refractory to conventional treatment, as demonstrated by this case report.
Case Report (n=1)
Myxedema heart disease should be considered in patients presenting with unexplained heart failure refractory to conventional treatment.
May support thyroid testing in refractory HF; hypothesis-generating case report leaves validation open.
BACKGROUND: Myxedema heart disease is an extremely rare disease entity and should be suspected in patients with unexplained heart failure refractory to conventional treatment. Myxedema coma with co- existent heart disease is not well known and very few cases have been reported. CONCLUSION: Here, we present an interesting case of myxedema coma with severe valvular cardiomyopathy followed by a concise review of the literature with special emphasis on epidemiology, pathophysiology, diagnosis and therapeutic modalities.
No takes yet. Share an insight, caveat, or question.
Grazette et al. (2018) conducted a case report in Myxedema heart disease (n=1). Myxedema coma with severe valvular cardiomyopathy was evaluated. Myxedema heart disease is a rare entity that should be suspected in patients with unexplained heart failure refractory to conventional treatment, as demonstrated by this case report.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: